FAQ

cisplatin/flavopiridol/paclitaxel

Known as: CDDP/FLAVO/TAX 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2016
012319992016

Related topics

Related topics

4 relations
Alvocidib HydrochlorideCisplatinFlavopiridolPaclitaxel

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
cisplatin/flavopiridol/paclitaxel
Cisplatin
Paclitaxel
Flavopiridol
Alvocidib Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cells
Dormant cells are characterised by low RNA synthesis. In contrast, cancer cells can be addicted to high RNA synthesis, including… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies
Imatinib is an inhibitor of the Bcr-Abl tyrosine kinase; however, resistance is common. Flavopiridol, a cyclin-dependent kinase… (More)
  • table 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
Review
2012
Review
2012
Mechanism of Nitric Oxide Synthase Regulation: Electron Transfer and Interdomain Interactions.
Nitric oxide synthase (NOS), a flavo-hemoprotein, tightly regulates nitric oxide (NO) synthesis and thereby its dual biological… (More)
Is this relevant?
2011
2011
The content of phenolic acids in plant aqueous extracts made from prevalent weeds
When considering the idea of sustainable development, as desirable future of our civilization, we tend to focus attention on… (More)
  • table 1
Is this relevant?
2010
2010
A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer.
BACKGROUND Flavopiridol (HMR 1275) is a synthetic flavone with antineoplastic properties through inhibition of cyclin-dependent… (More)
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
2007
2007
A pr 2 00 8 The Phases of Non-Compact QED 3
Non-compact three-dimensional QED is studied by computer s imulations to understand its chiral symmetry breaking features for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
The Phases of Non-Compact QED 3
Non-compact three-dimensional QED is studied by computer s imulations to understand its chiral symmetry breaking features for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Flavopiridol-related proinflammatory syndrome is associated with induction of interleukin-6.
BACKGROUND Flavopiridol is a flavonoid with antiproliferative effects mediated, in part, by inhibition of cyclin-dependent… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Flavopiridol binds to duplex DNA.
Flavopiridol, the first potent cyclin-dependent kinase inhibitor to enter clinical trials, was recently found to be cytotoxic to… (More)
Is this relevant?
1999
1999
Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants.
This study investigates the roles of both ionized and un-ionized species of flavopiridol in solubilization by complexation… (More)
Is this relevant?